Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy.
AUTHORS
Morgans
AK ,
Fan
KH ,
Koyama
T ,
Albertsen
PC ,
Goodman
M ,
Hamilton
AS ,
Hoffman
RM ,
Stanford
JL ,
Stroup
AM ,
Resnick
MJ ,
Barocas
DA ,
Penson
DF ,
. The Journal of urology. 2015 4 1; 193(4). 1226-31
- PMID: 25451829 [PubMed].
ABSTRACT
Observational data suggest that androgen deprivation therapy increases the risk of diabetes and cardiovascular disease. Using data from the population based PCOS we evaluated whether age at diagnosis and comorbidity impact the association of androgen deprivation therapy with incident diabetes and cardiovascular disease.
Observational data suggest that androgen deprivation therapy increases the risk of diabetes and cardiovascular disease. Using data from the population based PCOS we evaluated whether age at diagnosis and comorbidity impact the association of androgen deprivation therapy with incident diabetes and cardiovascular disease.
Tags: Alumni Publications 2015